Evidence map›Paper›PMID 31793743›Full record

ArticleEMBO molecular medicine2020

Endothelial MT1-MMP targeting limits intussusceptive angiogenesis and colitis via TSP1/nitric oxide axis.

Sergio Esteban, Cristina Clemente, Agnieszka Koziol, Pilar Gonzalo, Cristina Rius, Fernando Martínez, Pablo M Linares, María Chaparro, Ana Urzainqui, Vicente Andrés and 3 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Wnt3a is a promising target in colorectal cancer.Medical oncology (Northwood, London, England) · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Sergio EstebanVascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Cristina ClementeVascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Agnieszka KoziolVascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Pilar GonzaloVascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Cristina RiusVascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Fernando MartínezBioinformatics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Pablo M LinaresGastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBER-EHD), Universidad Autónoma de Madrid, Madrid, Spain.
María ChaparroGastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBER-EHD), Universidad Autónoma de Madrid, Madrid, Spain.
Ana UrzainquiImmunology Department, FIB-Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.
Vicente AndrésVascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.ORCID 0000-0002-0125-7209
Motoharu SeikiDivision of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Javier P GisbertGastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBER-EHD), Universidad Autónoma de Madrid, Madrid, Spain.
Alicia G ArroyoVascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.ORCID 0000-0002-1536-3846
Spanish National Centre for Cardiovascular Research · ESHospital Universitario de La Princesa · ES

Funding

Pro-CNIC FoundationSpanish Ministerio de Ciencia, Innovacion y Universidades SAF2014-52050-RSpanish Ministerio de Ciencia, Innovacion y Universidades SAF2017-83229-RSpanish Ministerio de Ciencia, Innovacion y Universidades SEV-2015-0505
6 · The paper itself

Abstract

Pathological angiogenesis contributes to cancer progression and chronic inflammatory diseases. In inflammatory bowel disease, the microvasculature expands by intussusceptive angiogenesis (IA), a poorly characterized mechanism involving increased blood flow and splitting of pre-existing capillaries. In this report, mice lacking the protease MT1-MMP in endothelial cells (MT1

Indexed as

ColitisMatrix Metalloproteinase 14Thrombospondin 1AnimalsEndothelial CellsHumansIntussusceptionMiceMice, Inbred C57BLNeovascularization, PathologicNitric OxideMatrix Metalloproteinase 14Nitric OxideThrombospondin 1inflammatory bowel diseaseintussusceptive angiogenesisMT1-MMPnitric oxideTSP1

Identifiers

PMID31793743
PMCPMC7005619
OpenAlexW2993697507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.